Lipoprotein Response Knockout Cell Lines

（Xu et al., Lipids Health Dis, 2025）

Research on Lipoprotein Response is shifting from single-gene or pathway-focused studies toward system-level functional analysis and regulatory network reconstruction.

Focusing on the core phenotype of abnormal lipid metabolism, research typically requires the integration of multiple regulatory factors—including receptors, transport proteins, enzymes, and transcriptional regulatory elements—to identify the critical nodes driving disease pathogenesis.

In practice, studies often combine high-throughput screening with functional validation strategies to systematically evaluate candidate genes and further characterize their context-dependent roles across different disease settings.

This workflow—from candidate discovery to functional validation and mechanistic confirmation—positions Lipoprotein Response as a critical bridge between basic research and target development.

With the advancement of CRISPR technologies, researchers can precisely perturb key regulatory factors in cell-based models, improving the efficiency and robustness of functional studies and accelerating the identification and validation of potential therapeutic targets.

· Cardiovascular Disease Research
Investigate the roles of LDL metabolism, cholesterol accumulation, and inflammation in atherosclerosis and identify key regulatory genes.

· Metabolic Disease Target Discovery
Explore lipid metabolism pathways, including lipoprotein uptake and reverse cholesterol transport, to uncover targets for obesity, diabetes, and dyslipidemia.

· Inflammation and Immune Regulation
Study how lipoproteins influence inflammatory signaling, such as oxidized LDL-induced immune activation and cytokine production.

· Cancer Metabolic Reprogramming
Examine how tumor cells adapt lipid utilization and depend on lipoprotein-mediated metabolic pathways.

· Drug Discovery and Functional Validation
Validate lipid-related targets (e.g., LDLR, APOE, PCSK9) using gene editing and screening approaches.

To support Lipoprotein Response research, EDITGENE has developed a portfolio of knockout cell models targeting key regulators involved in lipoprotein metabolism and signaling pathways. These standardized and well-characterized models enable efficient functional studies and mechanistic exploration.

The following products cover major targets and pathway components, supporting applications in lipid metabolism research, disease modeling, and drug discovery.